logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Life Science
Filter

Life Science

Categories

Sectors

Locations

Exchange

医药保险巨头CVS Health股价飙升的原因是什么?

Novo Nordisk’s Price Cuts and R&D Progress Go Hand in Hand, GLP-1 Drug Prices Reduced by Up to 50%

Mar 10, 2026

Life Science

Weight-Loss Truce: Hims & Hers Wins Novo Nordisk Deal, Soars 40%

Weight-Loss Truce: Hims & Hers Wins Novo Nordisk Deal, Soars 40%

Mar 9, 2026

Life Science

分析师指路下一个价值洼地:医疗保健股

Clinical Data Optimism Combined with Analyst Recommendation Drives Shattuck Labs Shares Up 53% This Week

Mar 6, 2026

Life Science

mRNA技术再突破!Moderna股价大涨

A Dividend Yield of Up to 4% and 48 Consecutive Years of Increases, Watch These Two Healthcare Giants

Mar 6, 2026

Life Science

高股息医疗股怎么选?强生与美敦力的优势与挑战

Alleviating Doctors’ Paperwork, Amazon Accelerates AI Healthcare Initiatives

Mar 5, 2026

Life Science

Up 100% Then Down 24%: Is the Moderna Pullback a Buying Opportunity?

Amtagvi’s Complex Path: Why Iovance Is Either a Home Run or a Strikeout

Mar 5, 2026

Life Science

Shorted-to-the-hilt KalVista rockets 39% as Chiesi swoops in with $1.9bn cash bid

Post-Casgevy Era: CRISPR’s Quandary vs. Vertex’s Moat

Mar 4, 2026

Life Science

Buffett’s UnitedHealth Bet Pays Off as Insurer Crushes Q1 Estimates

Despite Gains, These 2 Stocks Are Still Worth Buying

Mar 4, 2026

Consumer Goods, Life Science

这只生物科技股在2024年飙升116%,但在2025年值得买入吗?

Institutional Buying of PTC Therapeutics Attracts Attention, How Should Retail Investors Position Themselves?

Mar 4, 2026

Life Science

Alphabet vs. Meta: Which Digital Ad Titan Is the Smarter Buy Right Now?

Why Novartis Outshines Amarin as a Safe Bet in a Volatile Market

Mar 3, 2026

Life Science

Flu Season Fades, Abbott Stumbles: Is the 54-Year Dividend King Still Worth the Crown?

Teva’s Earnings Beat, Stock Doubles: Buy, Sell, or Hold?

Mar 2, 2026

Life Science

医疗保健精选——XBiotech完成向强生出售bermekimab,Acceleron Pharma与Fulcrum Therapeutics合作

Temptation of $150 Billion Weight Loss Drug Market Irresistible, Novo Nordisk Expands Production Against the Trend

Mar 2, 2026

Life Science

到2030年,这些股票可能是表现最佳的生物科技股

Structure Therapeutics Surges 214% in One Year, Faces Institutional Reduction Cashing Out USD 15.52 Million

Feb 27, 2026

Life Science

到2030年,这些股票可能是表现最佳的生物科技股

Analysts See 3x Upside Potential, Overlooked Cancer Diagnostics Company Telix Could Be an Investment Dark Horse

Feb 26, 2026

Life Science

百时美施贵宝押注未来,哪些管线将成为新增长支柱?

Following Billionaire Laffont? Analyzing the Investment Thesis for Moderna

Feb 25, 2026

Life Science

Hedge Fund BVF Makes Massive Bet on Structure Therapeutics as Stock Skyrockets 214%

Hedge Fund BVF Makes Massive Bet on Structure Therapeutics as Stock Skyrockets 214%

Feb 25, 2026

Life Science

Three Biotech Stocks Crushed the S&P 500 — Analysts Still Back Just One

What Will Drive Regeneron Pharmaceuticals in the Next Decade?

Feb 24, 2026

Life Science

Up 100% Then Down 24%: Is the Moderna Pullback a Buying Opportunity?

Gilead to Acquire Arcellx for Up to $7.8 Billion, Doubling Down on Next-Generation CAR-T Therapy

Feb 24, 2026

Life Science

  • ‹‹ Previous
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada